A prospective analysis of blood donation history and risk of non-Hodgkin lymphoma

References

• Muller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005; 84: 1–12.
   PubMed Web of Science ®Google Scholar
• Alexander DD, Mink PJ, Adami HO, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007; 120(Suppl 12): 1–39.
   PubMed Web of Science ®Google Scholar
• Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 405–408.
   PubMed Web of Science ®Google Scholar
• Lan Q, Zhang L, Tang X, et al. Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markers. Carcinogenesis 2010; 31: 1592–1596.
   PubMed Web of Science ®Google Scholar
• Saberi Hosnijeh F, Krop EJ, Scoccianti C, et al. Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2010; 19: 1577–1584.
   PubMed Web of Science ®Google Scholar
• Marquet RL, Hoynck van Papendrecht MA, Busch OR, et al. Blood donation leads to a decrease in natural killer cell activity: a study in normal blood donors and cancer patients. Transfusion 1993; 33: 368–373.
   PubMed Web of Science ®Google Scholar
• Karger R, Weber C, Schmidt J, et al. Characterization of immune system alterations following preoperative autologous blood donation for elective hip replacement surgery. Transfus Med 2007; 17: 45–53.
   PubMed Web of Science ®Google Scholar
• Lasek W, Plodziszewska M, Jakobisiak M. The effect of blood donation on natural killer activity in man. J Clin Lab Immunol 1987; 22: 165–168.
   PubMedGoogle Scholar
• Edgren G, Reilly M, Hjalgrim H, et al. Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst 2008; 100: 572–579.
   PubMed Web of Science ®Google Scholar
• Edgren G, Tran TN, Hjalgrim H, et al. Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion 2007; 47: 2017–2024.
   PubMed Web of Science ®Google Scholar
• Merk K, Mattsson B, Mattsson A, et al. The incidence of cancer among blood donors. Int J Epidemiol 1990; 19: 505–509.
   PubMed Web of Science ®Google Scholar
• Lasek W, Jakobisiak M, Stoklosa T. Decreased natural killer cell activity in whole-blood donors does not seem to result in increased cancer incidence. Transfusion 1994; 34: 359–360.
   PubMed Web of Science ®Google Scholar
• Vahidnia F, Hirschler NV, Agapova M, et al. Cancer incidence and mortality in a cohort of US Blood Donors: a 20-year study. J Cancer Epidemiol 2013; 2013: 814842.
   PubMedGoogle Scholar
• Morton LM, Wang SS, Cozen W, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 2008; 112: 5150–5160.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer (IARC) Press; 2008.
   Google Scholar
• Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007; 110: 695–708.
   PubMed Web of Science ®Google Scholar
• Turner JJ, Morton LM, Linet MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 2010; 116: e90–98.
   PubMed Web of Science ®Google Scholar
• Diver WR, Patel AV, Thun MJ, et al. The association between cigarette smoking and non-Hodgkin lymphoid neoplasms in a large US cohort study. Cancer Causes Control 2012; 23: 1231–1240.
   PubMed Web of Science ®Google Scholar
• Bertrand KA, Giovannucci E, Zhang SM, et al. A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma. Cancer Prev Res (Phila) 2013; 6: 864–873.
   PubMed Web of Science ®Google Scholar
• Kelly JL, Fredericksen ZS, Liebow M, et al. The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender. Ann Epidemiol 2012; 22: 855–862.
   PubMed Web of Science ®Google Scholar
• Morton LM, Zheng T, Holford TR, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol 2005; 6: 469–476.
   PubMed Web of Science ®Google Scholar
• Curado M-P, Edwards B, Shin HR, et al. Cancer incidence in five continents. Volume IX. Lyon: IARC Press, International Agency for Research on Cancer; 2007.
   Google Scholar
• Smith-Warner SA, Spiegelman D, Ritz J, et al. Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 2006; 163: 1053–1064.
   PubMed Web of Science ®Google Scholar
• Anderson TW. Introduction to multivariate statistics. New York: John Wiley & Sons; 1984.
   Google Scholar
• Chapman DG, Nam JM. Asymptotic power of chi square tests for linear trends in proportions. Biometrics 1968; 24: 315–327.
   PubMed Web of Science ®Google Scholar
• Atsma F, Veldhuizen I, Verbeek A, et al. Healthy donor effect: its magnitude in health research among blood donors. Transfusion 2011; 51: 1820–1828.
   PubMed Web of Science ®Google Scholar
• Ekstrom Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008; 111: 4029–4038.
   PubMed Web of Science ®Google Scholar
• Edlefsen KL, Martinez-Maza O, Madeleine MM, et al. Cytokines in serum in relation to future non-Hodgkin lymphoma risk: Evidence for associations by histologic subtype. Int J Cancer 2014; 135: 913–922.
   PubMed Web of Science ®Google Scholar
• Vendrame E, Hussain SK, Breen EC, et al. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk. Cancer Epidemiol Biomarkers Prev 2014; 23: 343–349.
   PubMed Web of Science ®Google Scholar
• Lewis SL, Kutvirt SG, Simon TL. Investigation of the effect of long-term whole blood donation on immunologic parameters. Transfusion 1992; 32: 51–56.
   PubMed Web of Science ®Google Scholar
• Lewis SL, Kutvirt SG, Bonner PN, et al. Plasma proteins and lymphocyte phenotypes in long-term plasma donors. Transfusion 1994; 34: 578–585.
   PubMed Web of Science ®Google Scholar
• Tran-Mi B, Storch H, Seidel K, et al. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers. Vox Sang 2004; 86: 189–197.
   PubMed Web of Science ®Google Scholar
• Schulzki T, Seidel K, Storch H, et al. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA). Vox Sang 2006; 91: 162–173.
   PubMed Web of Science ®Google Scholar
• Bertalli NA, Allen KJ, McLaren CE, et al. A comparison of self-reported and record-linked blood donation history in an Australian cohort. Transfusion 2011; 51: 2189–2198.
   PubMed Web of Science ®Google Scholar
• Zhang X, Ma J, Wu K, et al. Blood donation and colorectal cancer incidence and mortality in men. PLoS One 2012; 7: e39319.
   PubMed Web of Science ®Google Scholar